Obstructive sleep apnoea in craniofacial microsomia: a systematic review

C J J M Caron1, B I Pluijmers1, K F M Joosten1

  • 1The Dutch Craniofacial Centre, Department of Oral and Maxillofacial Surgery, Erasmus University Medical Centre, Sophia's Children's Hospital Rotterdam, Rotterdam, Netherlands.

Insights

Children with craniofacial microsomia (CFM) have a high risk of obstructive sleep apnoea (OSA). This review found a wide prevalence range (7-67%) of OSA in CFM patients, highlighting the need for further research.

Area of Science:

  • Pediatric Medicine
  • Otolaryngology
  • Sleep Medicine

Background:

  • Craniofacial microsomia (CFM) is a congenital condition affecting facial development.
  • Children with CFM often experience airway abnormalities, increasing their risk for obstructive sleep apnoea (OSA).

Purpose of the Study:

  • To systematically review the existing literature on the prevalence of OSA in pediatric patients diagnosed with CFM.
  • To synthesize current data on OSA diagnosis, treatment, and outcomes in this population.

Main Methods:

  • A comprehensive literature search was conducted across major databases (PubMed, Embase, Cochrane Library, Web of Science).
  • Included studies reported on CFM patients, OSA presence, polysomnography findings, and treatment outcomes.
  • Data extraction focused on patient numbers, characteristics, OSA prevalence, and management strategies.

Main Results:

  • Sixteen articles met the inclusion criteria; four reported OSA prevalence ranging from 7% to 67%.
  • Surgical interventions were more frequently documented than conservative treatments for OSA in CFM patients.
  • The literature suggests a link between CFM and OSA, but data quality is variable.

Conclusions:

  • OSA is a significant concern for children with craniofacial microsomia.
  • Current evidence is limited by a lack of prospective studies and objective measurements.
  • Further high-quality prospective research is essential to accurately determine OSA prevalence and guide management in CFM patients.